Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Vidutolimod |
Trade Name | |
Synonyms | CMP-001|CYT003|CYT 003|CYT-003|ARB-1598|QbG10 |
Drug Descriptions |
Vidutolimod (CMP-001) comprises a Toll-like receptor 9 (TLR-9) agonist encapsulated within a virus-like particle, which may lead to enhanced antitumor immune response and inhibition of tumor growth (PMID: 34326162). |
DrugClasses | TLR9 Agonist 9 |
CAS Registry Number | 147063-80-7 |
NCIT ID | C126422 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + Vidutolimod | Atezolizumab Vidutolimod | 0 | 1 |
Avelumab + Vidutolimod | Avelumab Vidutolimod | 0 | 0 |
Cemiplimab + Vidutolimod | Cemiplimab Vidutolimod | 0 | 1 |
INCAGN01949 + Vidutolimod | INCAGN01949 Vidutolimod | 0 | 1 |
Nivolumab + Vidutolimod | Nivolumab Vidutolimod | 0 | 5 |
Pembrolizumab + Vidutolimod | Pembrolizumab Vidutolimod | 0 | 5 |
Vidutolimod | Vidutolimod | 0 | 1 |